Onconetix, Inc. (ONCO)

NASDAQ: ONCO · Real-Time Price · USD

0.6501

-0.0094 (-1.43%)

Feb 26, 2026, 2:56 PM EST - Market open

Onconetix Employees

Onconetix had 5 employees as of December 31, 2024. The number of employees decreased by 7 or -58.33% compared to the previous year.

Employees

5

Change (1Y)

-7

Growth (1Y)

-58.33%

Revenue / Employee

$244,750

Profits / Employee

-$10,169,074

Market Cap

1.01M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	5	-7	-58.33%
Dec 31, 2023	12	0	-
Dec 31, 2022	12	7	140.00%
Dec 31, 2021	5	-	-
Sep 30, 2021	2	-	-
Jun 30, 2021	2	-	-

Related Stocks

Company Name	Employees
Aditxt	26
Virax Biolabs Group	19
Biodexa Pharmaceuticals	13
Azitra	12
Ensysce Biosciences	8
CDT Equity	6
CNS Pharmaceuticals	5
XORTX Therapeutics	3

Employee Rankings

ONCO News

12 days ago - Onconetix, Inc. (ONCO) M&A Call Transcript - Seeking Alpha
14 days ago - Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company - GlobeNewsWire
14 days ago - Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer - Business Wire
5 months ago - Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewsWire
5 months ago - Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement - GlobeNewsWire
5 months ago - Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM - GlobeNewsWire
8 months ago - Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement - GlobeNewsWire
9 months ago - Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel - GlobeNewsWire